STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
Q-Med (STO:QMED)
* Group revenues from sales of goods and royalties amounted to 665.0 (686.2) MSEK during the period.
* Growth within the Esthetics product area was 17 percent and revenues amounted to 537.1 (460.8) MSEK.
* Operating income amounted to 318.2 (212.9) MSEK and the operating margin was 47.9 (34.7) percent.
